Protective effects of thymoquinone and desferrioxamine against hepatotoxicity of carbon tetrachloride in mice

Life Sciences

Volumn 66, Issue 26, 2000, Pages 2583-2591

  Mansour, Mahmoud A ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Carbon tetrachloride; Desferrioxamine; Hepatotoxicity; Thymoquinone

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CARBON TETRACHLORIDE; DEFEROXAMINE; DEFEROXAMINE MESYLATE; LACTATE DEHYDROGENASE; THYMOQUINONE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LIPID PEROXIDATION; LIVER PROTECTION; LIVER TOXICITY; MALE; MOUSE;

ANIMALIA;

EID: 0034686073     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(00)00592-0     Document Type: Article

References (39)

1. 1. N. Stacey and B.G. Priestly, Toxicol. Appl. Pharmacol. 45 29-239 (1978).
2. 2. R. Chenery, M. George and G. Krishna, Toxicol. Appl. Pharmacol. 60 241-252 (1981).
3. 3. P.D. Mccay, E.K. Lai, J.L. Poyer, C.M. Dubose and E.D Janzen, J. Biol. Chem. 259 2135-2143 (1984).
4. 4. P. Letteron, G. Labbe, C. Degott, A. Berson, B. Fromenty, M. Delaforge, D. Larrey and D. Passayre, Biochem. Pharmacol. 39 2027-2034 (1990).
5. 5. R.O. Recknagel, Life Sci. 33 401-408 (1983).
6. 6. G. Minotti and S.D. Aust, Chem. Biol. Interact. 71 1-29 (1989).
7. 7. I.G. Sipes, G. Krishna and J.R. Gillette, Life Sci. 20 1541-1568 (1977).
8. 8. M. Younes and C. P. Siegers, Chem. Biol. Interact. 55 327-334 (1985)
9. 9. J.A. Castro, V. Cignoli, C.R. Decastro and O.M. Defenos, Biochem. Pharmacol. 21 49-57 (1972).
10. 10. T. Icho, S. Kojima, N. Shimhara, Y. Kajiwara, K. Kitabatake, and K. Kubota, Biochem. Pharmacol.45 1953-1958 (1993).
11. 11. S.P. Ip and K.M. Ko, Biochem. Pharmacol. 52 1687-1693 (1996).
12. 12. T. Yao, S.D. Esposti, L. Huang, R. Arnon, A. Spangenberger, and M. Zern, Am.J. Physiol. 267 G476-G484(1994).
13. 13. C.D. Klaasen. In: Gilman AG., Goodman LS, Rall TW, Murad F (eds)in: The Pharmacological basis of therapeutics. Macmillan, New York, Toronto, London. P16224 (1982)
14. 14. C.P. Siegers, B. Steffen, and M. Younes, Pharm. Res. Commun. 20 337-343 (1988).
15. 15. W.X. Ding, H.M. Shen, H.G. Zhu and C.N. Ong, Environ. Res. 78 12-18 (1998).
16. 16. E.A. Aboutabl, A.A. El-Azzouny and F.J. Hammarschmidt, In: Brunke EJ. De Grujter (ed) in: Prog. Essent. Oil Res. Proc. Int. Symp. Essent. Oils. Berlin. 49-55(1986).
17. 17. P.J. Houghton, R.S. Zarka, B. De-Las-Heras and J. R. Hoult, Planta Med 61 33-36 (1995).
18. 18. M.N. Nagi and M.A. Mansour, Pharm. Res. Accepted (1999).
19. 19. T.F. Slater. Biochem. J. 222 1-15 (1984)
20. 20. D. F. Muldoon, E.A. Hassoun, S. J. Stohs. Res. Commun. Mol. Pathol. Pharmacol. 92 107-118 (1996).
21. 21. N. Al-Gharably, O. Badary, M. Nagi, O. Al-Shabanah, H. Al-Sawaf, A. Rikabi and A. Al-Bekairi, Res. Commun. Pharm. Toxicol. 2 41-50 (1997).
22. 22. H.U. Bergemeyer, P. Scheibe and A.W. Wahlefeld, Clin. Chem. 24 58-73 (1978).
23. 23. S.N. Buhl and K.Y. Jackson, Clin. Chem. 24 828-831 (1978).
24. 24. H. Ohkawa, N. Ohishi and K. Yagi, Anal. Biochem. 95 351-358 (1979).
25. 25. G.L. Ellman, Arch. Biochem.Biophys. 82 70-77 (1959).
26. 26. C.P. Higgings, R.L. Bachner, J. McCallister and L.A. Boxer, Proc. Soc. Exp. Biol. Med. 158 478-481(1978).
27. 27. J. Camps, T. Bargallo and A. Gimenez, Clin. Sci. 83 695-700(1992).
28. 28. M. Younes and C.P. Siegers, Res. Commun. Chem. Pathol. Pharmacol. 27 119-128(1980).
29. 29. K. Nakagawa, Arch. Toxicol. 67 686-690 (1993).
30. 30. J.F. Brady, F. Xiao, M.H. Wang, Y. Li, S.M. Ning, J.M. Gapac and C.S. Yang, Toxicol. Appl. Pharmacol. 108 366-373(1991).
31. 31. K.S. Min, Y. Terano, S. Onosaka and K. Tanaka, Toxicol. Appl. Pharmacol. 113 74-79(1992).
32. 32. N.H. Stacy and C.D. Classen, Toxicol. Appl. Pharmacol. 58 8-18(1981).
33. 33. V.A. Kostiuk. Biochemie 56 109-114 (1991).
34. 34. M.H. Daba and M.S. Abdel-Rahman, Toxicol. Lett. 95 23-29 (1998)
35. 35. A. Al-Bekairi, A.M. Osman, M.A. Hafez and M.M. Al-Harbi, Drug Develop. Res. 29 56-62 (1993).
36. 36. O. Al-Shabanah, O. Badary, M. Nagi, N. Al-Gharably, A. Al-Rikabi and A. Al-Bekairi, Exp. Clin. Cancer Res. 26 107-109 (1998).
37. 37. A. Osman, O. Al-Shabanah, M. Al-Harbi, N. Al-Gharably, A. Al-Bekairi, H. Tawfik and S. Aziz, Med. Sci. Res. 21 193-194(1993).
38. 38. O.A. Badary, M.N. Nagi, O. Al-Shabanah, H. Al-Sawaf, M. Al-Sohaibani and A. Al-Bekairi, Cana. J. Physiol. Pharmacol. 75 1356-1361(1997).
39. 39. M. Al-Harbi, A. Osman, N. Al-Gharably, A. Al-Bekairi, O. Al-Shabanah, D. Sabah and M. Raza, Chemotherapy 41 448-454 (1995).